Skip to Content
Coronavirus

US clears Moderna vaccine for COVID-19, 2nd shot in arsenal

WASHINGTON (AP) - The U.S. is adding a second COVID-19 vaccine to its arsenal.

The Food and Drug Administration authorized emergency use Friday of the vaccine developed by Moderna and the National Institutes of Health.

The decision comes days after health workers and nursing home residents began getting a similar coronavirus shot from Pfizer and BioNTech.

Extra doses from a second vaccine are urgently needed, as U.S. deaths hit all-time highs and some hospitals are running out of beds.

But even with additional candidates in the pipeline, there won’t be enough for the general population until spring, and shots will be rationed in the meantime.

Email Alert – Breaking News / News

Associated Press

Comments

1 Comment

  1. “The Food and Drug Administration authorized emergency use”
    Which means it bypassed normal qualifications previous vaccines were subject to. It normally takes 5-10 years to gain approval. This one is delivered in a few months. With ZERO testing for long term safety. For all we know, everyone who takes this vaccine will be dead in a couple of years. Facts are often unpleasant. If you prefer to ignore them, by all means take the vaccine.

Leave a Reply

Skip to content